Thus, MPO is recognized as a major player in health and disease and several studies have been advertising it as a potential biomarker for cardiovascular diseases (CVDs) because of its ubiquitous presence in atheroma plaques where it modifies LDL into its oxidized form, leading to the initiation of inflammatory pathways and affecting the progression of the atherosclerotic disease [2]. The gene discussed is MPO; the disease is cardiovascular disorder.